Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8728690rdf:typepubmed:Citationlld:pubmed
pubmed-article:8728690lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0078981lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0268362lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0001898lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0017890lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0018946lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0033382lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C1332773lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0041457lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C1524075lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C1979845lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C1706204lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C1555721lld:lifeskim
pubmed-article:8728690lifeskim:mentionsumls-concept:C0337112lld:lifeskim
pubmed-article:8728690pubmed:issue3lld:pubmed
pubmed-article:8728690pubmed:dateCreated1996-10-10lld:pubmed
pubmed-article:8728690pubmed:abstractTextThe features of a child with osteogenesis imperfecta type III (OI III) resulting from the heterozygous substitution of glycine 1006 by alanine in the pro alpha 2(I) chain of type I procollagen were studied. He was born at term with the clinical features of severe OI, including deep grey-blue sclerae. He had severe osteopenia and all long bones were smaller than normal with cortical thinning, metaphyseal expansion, poor metaphyseal modelling, and multiple fractures. However, the vertebrae, pelvis, and shoulder girdle were of normal shape and there were few rib fractures. Histological examination of the calvarium and tibial shaft showed woven bone without lamellar bone or Haversian systems. The shafts of the long bones were widened owing to repeated fractures. Progressive enlargement of the calvarium occurred between 3 and 4.5 months of age owing to bilateral chronic subdural haematomata and a large arachnoid cyst in the Sylvian fissure. The cyst was probably developmental in origin while the subdural collections were probably the result of perinatal skull trauma. The cyst and the subdural collections resolved following drainage but ventricular dilatation with normal cerebrospinal fluid pressure followed. The proband is the first reported case of OI with a glycine substitution by alanine in the pro alpha 2(I) chain of type I procollagen.lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:languageenglld:pubmed
pubmed-article:8728690pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:citationSubsetIMlld:pubmed
pubmed-article:8728690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8728690pubmed:statusMEDLINElld:pubmed
pubmed-article:8728690pubmed:monthMarlld:pubmed
pubmed-article:8728690pubmed:issn0022-2593lld:pubmed
pubmed-article:8728690pubmed:authorpubmed-author:ColeW GWGlld:pubmed
pubmed-article:8728690pubmed:authorpubmed-author:CHIH PHPlld:pubmed
pubmed-article:8728690pubmed:issnTypePrintlld:pubmed
pubmed-article:8728690pubmed:volume33lld:pubmed
pubmed-article:8728690pubmed:ownerNLMlld:pubmed
pubmed-article:8728690pubmed:authorsCompleteYlld:pubmed
pubmed-article:8728690pubmed:pagination193-6lld:pubmed
pubmed-article:8728690pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:meshHeadingpubmed-meshheading:8728690-...lld:pubmed
pubmed-article:8728690pubmed:year1996lld:pubmed
pubmed-article:8728690pubmed:articleTitleArachnoid cyst and chronic subdural haematoma in a child with osteogenesis imperfecta type III resulting from the substitution of glycine 1006 by alanine in the pro alpha 2(I) chain of type I procollagen.lld:pubmed
pubmed-article:8728690pubmed:affiliationCentre for the Study of Heritable Connective Tissue Disorders, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.lld:pubmed
pubmed-article:8728690pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8728690pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:8728690pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed